Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Gastrointestinal Toxicity × Gynecologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1 Gastrointestinal 1

Conditions

Ovarian Neoplasms 994 Uterine Cervical Neoplasms 419 Endometrial Neoplasms 346 Breast Neoplasms 292 Carcinoma, Non-Small-Cell Lung 288 Neoplasms 238 Colorectal Neoplasms 230 Fallopian Tube Neoplasms 208 Stomach Neoplasms 191 Pancreatic Neoplasms 184 Melanoma 157 Prostatic Neoplasms 151 Triple Negative Breast Neoplasms 147 Carcinoma, Ovarian Epithelial 144 Lung Neoplasms 136 Neoplasm Metastasis 131 Squamous Cell Carcinoma of Head and Neck 130 Carcinoma, Renal Cell 129 Head and Neck Neoplasms 121 Esophageal Neoplasms 121 Urinary Bladder Neoplasms 113 Small Cell Lung Carcinoma 88 Sarcoma 80 Carcinoma, Hepatocellular 76 Recurrence 69 Carcinoma, Transitional Cell 69 Uterine Cervical Dysplasia 65 Papillomavirus Infections 65 Colonic Neoplasms 59 Cholangiocarcinoma 56

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02351089 2020-03-05

ProRad

Probi AB

Phase NA Terminated

GastrointestinalGynecologic

Gastrointestinal Toxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡